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ORIGINAL ARTICLE
A Minority of Patients with Type 1 Diabetes
Routinely Downloads and Retrospectively
Reviews Device Data
Jenise C. Wong, MD, PhD,1 Aaron B. Neinstein, MD,2
Matthew Spindler, BA,1 and Saleh Adi, MD1
Abstract
Background: In type 1 diabetes (T1D), periodic review of blood glucose and insulin dosing should be per-
formed, but it is not known how often patients review these data on their own. We describe the proportion of
patients with T1D who routinely downloaded and reviewed their data at home.
Materials and Methods: A cross-sectional survey of 155 adults and 185 caregivers of children with T1D at a
single academic institution was performed. ‘‘Routine Downloaders’’ (downloaded four or more times in the past
year) were also considered ‘‘Routine Reviewers’’ if they reviewed their data most of the time they downloaded
from devices. Logistic regression was used to identify factors associated with being a Routine Reviewer.
Results: Only 31% of adults and 56% of caregivers reported ever downloading data from one or more devices,
whereas 20% and 40%, respectively, were considered Routine Downloaders. Only 12% of adults and 27% of
caregivers were Routine Reviewers. Mean hemoglobin A1c was lower in Routine Reviewers compared with non-
Routine Reviewers (7.2– 1.0% vs. 8.1– 1.6% [P= 0.03] in adults and 7.8– 1.4% vs. 8.6– 1.7% [P= 0.001] in
children). In adjusted analysis of adults, the odds ratio of being a Routine Reviewer of one or more devices for every
10-year increase in age was 1.5 (95% confidence interval, 1.1, 2.1 [P= 0.02]). For every 10 years since diabetes
diagnosis, the odds ratio of being a Routine Reviewer was 1.7 (95% confidence interval, 1.2, 2.4 [P= 0.01]). For
caregivers, there were no statistically significant factors associated with being a Routine Reviewer.
Conclusions: A minority of T1D patients routinely downloads and reviews data from their devices on their
own. Further research is needed to understand obstacles, provide better education and tools for self-review, and
determine if patient self-review is associated with improved glycemic control.
Introduction
For patients with type 1 diabetes (T1D), optimal gly-cemic control requires intensive insulin management to
prevent short- and long-term complications.1–3 Flexible in-
tensive insulin therapy, shown to improve quality of life and
glycemic control, requires adjustment of insulin doses based
on current blood glucose level and carbohydrate intake and
encourages regular review of past data to inform changes in
carbohydrate ratios and insulin sensitivity factors.4–6 These
ratios and factors must be optimized for each patient and
should be evaluated and adjusted frequently as insulin re-
quirements change.7,8
Blood glucose meters (BGMs), insulin pumps, and con-
tinuous glucose monitoring (CGM) have made the real-time
process of calculating and dosing insulin easier by facilitating
the collection of blood glucose and carbohydrate data and
suggesting doses with bolus calculators.9 In addition, these
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diabetes devices have automated the process of recording
blood glucose levels, carbohydrate equivalents, and insulin
doses, thus reducing the barrier of manual record-keeping
and making data more readily available for retrospective
review. Currently, proprietary software is required for pa-
tients at home, or their providers in the clinic, to download
information from the devices and display the data.10–12
Regular retrospective review of diabetes data is necessary to
adjust insulin regimens and to evaluate the effects of physical
activity, other medications, or dietary changes.13–18
Despite the importance of retrospectively reviewing dia-
betes data, most studies have focused on data review by
healthcare providers and not by patients themselves.12,19–21
The few studies that have described patient download of their
own data suggest that patients use retrospective functions of
their devices less often than they do real-time functions.22,23
In a study of insulin pumps, patients who were instructed to
download their pump data weekly did so only 2.2 times/
month; it was not reported whether patients reviewed the
retrospective data summaries on their own.24 In another
study, pump users were asked to download data monthly, but
only half the participants downloaded three or more times in a
4-month period.12 In the T1D Exchange Clinic Registry,
users of CGM found the real-time functions of CGM more
useful than the retrospective functions, with many users
never downloading data from their CGM device.23 Only 27%
of participants reported downloading data from their CGM
device at least monthly, and £ 15% did this weekly.23
In clinical practice, a patient might download device data
to his or her computer and then send or give access to the data
to their diabetes provider for guidance, without reviewing the
information him- or herself. This might be due to lack of time
or uncertainty about what to do with the downloaded infor-
mation. Alternatively, a patient might review the data on his
or her own to help him or her adjust the insulin regimen or
daily routine, either with or without the help of a provider. To
our knowledge, no studies have specifically described the
frequency of retrospective self-review of device data by pa-
tients at home. Although diabetes providers often use past
device data to recommend changes in insulin regimens, it is
not known if patients use or find value in downloading and
reviewing device data. Knowing how often patients down-
load data from their devices and review them on their own at
home may help direct device education efforts and the way
this information is presented to patients.
In this cross-sectional study of one adult and one pediatric
diabetes clinic, we examined the frequency of patient down-
load and retrospective review of device data. We identified
users who routinely downloaded and reviewed data from their
devices and looked for demographic, socioeconomic, and
clinical factors associated with routine retrospective review of
data. Finally, we took an exploratory look at the reasons why
patients did not download their data. The results of this study
will help us understand how patients retrospectively use in-
formation from their diabetes devices and will inform future
areas and target groups for improved diabetes education.
Materials and Methods
Participants
Participants were male and female adults ‡18 years with
T1D and caregivers of children <18 years with T1D who
received care at the adult or pediatric tertiary diabetes center
at a single institution. T1D diagnosis was ascertained from
the electronic health record. Patients with other forms of
diabetes (e.g., type 2, cystic fibrosis-related, medication-
induced) were excluded.
All participants received insulin by injections using the
basal-bolus method or by insulin pump; those who were not
using insulin, were on basal insulin only, or were on fixed-
dose regimens were excluded. All were required to have an
understanding of written English. Patients in our centers
typically have clinic visits every 2–3 months, with mea-
surement of hemoglobin A1c (A1c), as per American Dia-
betes Association guidelines.13 Participants not seen every
2–3 months with measurement of A1c were excluded. All
participants in the pediatric clinic using insulin pumps or
CGM completed device use education prior to device initi-
ation, including how to download data to home computers
and upload to device manufacturers’ software, websites, and/
or patient portals. Training was provided by diabetes center
staff and/or by a device company trainer. Teaching on
downloading data was done on an individual basis in the adult
clinic. Any hardware necessary for downloading was either
provided with the device or was freely available to patients
from the manufacturers. Potential participants were recruited
by consecutive sampling at routine clinic visits. After pro-
viding informed consent, participants completed an elec-
tronic cross-sectional survey in the clinic.
The protocol and procedures were approved by the
Institutional Review Board at the University of California
San Francisco.
Measurements
Participants answered questions about use of diabetes de-
vices, the frequency of BGM use, pump, and/or CGM data
download, and how often they reviewed the downloaded data
at home. A participant was considered a ‘‘Routine Down-
loader’’ of a device if he or she downloaded data from that
device at least once between routine clinic visits every 3
months, which was four or more times in the past year. A
Routine Downloader was also considered to be a ‘‘Routine
Reviewer’’ of data from a particular device if he or she ret-
rospectively reviewed the data from that device at least
‘‘most of the time’’ he or she downloaded (given the choices
of ‘‘Never,’’ ‘‘Some of the time,’’ ‘‘Most of the time,’’ and
‘‘Every time I downloaded’’).
Participants provided demographic (age, sex, race/ethnic-
ity), socioeconomic (insurance, highest level of education of
the adult patient or caregiver of a child), and clinical (time
since diagnosis, devices used) information on the survey. The
A1c from that clinic visit, or from another measurement
within 1 month of the visit, was obtained from the electronic
health record. A1c was obtained by point-of-care testing or
laboratory draw. Laboratory measurement was by the Bio-
Rad (Hercules, CA) Variant II Turbo 2.0 and the Bio-Rad
D-10 high-performance liquid chromatography systems, and
point-of-care testing A1c was measured by the DCA Van-
tage analyzer from Siemens (Malvern, PA). The DCA
Vantage analyzer has exhibited intra- and interassay coeffi-
cients of variation lower than 2.6% and 4%, respectively, and
correlates with the comparison high-performance liquid
chromatography method (r2 = 0.9776).25
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Statistical analysis
Data from adults and data from caregivers of children were
analyzed separately. Frequencies of downloading at least once
in the past year, of being a ‘‘Routine Downloader,’’ and of
being a ‘‘Routine Reviewer’’ of data from each device were
reported as proportions of all users of that device, based on
self-report. If a participant was a ‘‘Routine Reviewer’’ of data
from one or more devices (BGM, pump, or CGM device), he or
she was considered to be a ‘‘Routine Reviewer’’ of one or more
devices in further analysis. Descriptive statistics (t tests for
continuous variables and v2 tests for dichotomous variables)
were used to compare Routine Reviewers of data from one or
more devices with those who were not Routine Reviewers.
Multivariate logistic regression was used to look for associa-
tions of demographic, socioeconomic, and clinical factors with
Routine Reviewer status. Linear regression was used to look
for the association between being a Routine Reviewer of data
from one or more devices with A1c, controlling for possible
confounding factors. All statistical analyses were performed
using Stata version 12.1 software (StataCorp, College Station,
TX). For all statistical tests, significance was set to a= 0.05.
Results
Participant characteristics
In total, 340 participants completed the survey (155 adults
‡18 years with T1D and 185 caregivers of children with
T1D). The youngest was 1.3 years, and the oldest was 83.4
years. The study population had a median age of 17.2 years
(interquartile range, 12.0, 26.5 years) and had similar de-
mographics to other T1D patient populations,26 with 52%
males, 22% ethnic minorities, 59% with at least a college
degree, and 79% with private insurance. The proportions of
participants using pumps (73%) and CGM (32%) were rela-
tively high compared with a national registry.26 Character-
istics of all participants are shown in Table 1.
Frequency of participants who downloaded
and reviewed data from diabetes devices
Only 31% of adults and 56% of caregivers of children
reported downloading data from one or more diabetes devices
at home at least once in the past year (Fig. 1A and E). For
adult patients, a greater proportion of those who used CGM
downloaded their CGM data (49%), compared with BGM
(22%) and pump (28%) users (Fig. 1B–D). For caregivers of
children, pump users were more likely to ever download their
data from their pumps (61%), compared with users of BGMs
(38%) or CGM (43%) (Fig. 1F–H).
‘‘Routine Downloaders’’ were those who downloaded data
from their device at least once between quarterly clinic visits,
or four or more times in the past year. Only 20% of adults and
40% of caregivers were Routine Downloaders from one or
more devices (Fig. 1A and E). A larger proportion of adult
CGM users were Routine Downloaders of CGM data (40%)
than BGM (12%) or pump (16%) users (Fig. 1B–D), and
larger proportions of caregivers of children using pumps were
Routine Downloaders (43%) compared with BGM (28%) and
CGM (29%) users (Fig. 1F–H).
Routine Downloaders who also reviewed their device data
the majority of the time they downloaded were defined as
‘‘Routine Reviewers.’’ Overall, only 12% of adults and 27%
of caregivers were Routine Reviewers of data from one or
more devices (Fig. 1A and E). There were larger proportions
of Routine Reviewers among adult users of CGM (28% vs.
5% of BGM users and 7% of pump users) and among care-
givers of children using pumps (27% vs. 19% of BGM users
and 22% of CGM users) (Fig. 1B–D and F–H).
Characteristics of Routine Reviewers
of at least one device
Characteristics of adults and children of caregivers who
were Routine Reviewers of data from one or more devices are
shown in Table 2. In both groups, the average A1c was lower
in Routine Reviewers compared with non-Routine Reviewers
(7.2 – 1.0% vs. 8.1 – 1.6% [P = 0.03] in adults and 7.8 – 1.4%
vs. 8.6 – 1.7% [P = 0.001] in children). Mean age and T1D
duration were significantly different in the Routine Reviewer
groups compared with the non-Routine Reviewers; however,
the direction of the relationship was opposite in the two groups.
Among adults, Routine Reviewers were older (44.9–13.1 years)
than non-Routine Reviewers (32.9–16.2 years) (P=0.003),
whereas among caregivers, the children of Routine Reviewers
were younger (10.8–4.0 years) than those of non-Routine Re-
viewers (12.3–3.9 years) (P=0.02). Similarly, adult Routine
Reviewers had diabetes longer compared with non-Routine
Reviewers (28.7 – 5.5 vs. 17.2 – 12.7 years; P = 0.0006),
whereas caregivers who were Routine Reviewers had chil-
dren with diabetes for less time compared with non-Routine
Reviewers (3.7 – 3.1 vs. 5.5 – 3.8 years; P = 0.005). There
were no statistically significant differences in the proportion
Table 1. Participant Characteristics
Adults
(n = 155)
Children
(n = 185)
Mean age (years) 34.5 – 16.4 11.9 – 4.0
Median age (years) 29.5 (20.2, 44.4) 12.5 (9.0, 15.1)
Sex (% male) 50% 54%
Ethnicity (% minority status) 24% 20%
White, not of Hispanic
origin (%)
66% 69%
Black/African
American (%)
6% 4%
Hispanic/Latino 10% 7%
Asian/Pacific Islander (%) 8% 6%
Other/mixed ethnicity (%) 6% 11%
Education level (% with
at least college degree)a
49% 67%
Insurance status (% with
private insurance)
77% 80%
Mean duration of type 1
diabetes (years)
18.5 – 13.5 4.9– 3.7
Mean A1c (%) 8.0 – 1.5 8.4– 1.6
Using blood glucose meterb 97% 97%
Using an insulin pumpb 68% 77%
Using continuous
glucose monitoringb
28% 36%
Data are mean– SD values, median values (interquartile range),
or frequencies, as indicated. The following were missing data:
ethnicity, n = 10; education level, n= 13; insurance status, n = 19;
duration of type 1 diabetes, n = 5.
aFor children, education level of caregiver.
bUse of a blood glucose meter, insulin pump, or continuous
glucose monitoring was not mutually exclusive.
A1c, hemoglobin A1c.
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FIG. 1. Frequency of patients who download and review their device data: (A) all adult device users (n= 154); (B) adult
blood glucose meter (BGM) users (n = 149); (C) adult pump users (n= 104); (D) adult continuous glucose monitoring
(CGM) users (n = 43); (E) all child device users (n = 182); (F) child BGM users (n = 175); (G) child pump users (n = 137);
and (H) child CGM users (n = 65). Device users may not be mutually exclusive. Usage was classified as ever download
(black bars), Routine Downloader (striped bars), or Routine Reviewer (white bars).
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of Routine Reviewers who were male versus female, ethnic
minorities, had at least a college degree, or private insur-
ance, compared with non-Routine Reviewers (Table 2).
However, there were trends toward smaller proportions of
ethnic minorities, larger proportions with at least a college
degree, and lower proportions without private insurance in
the Routine Reviewer groups.
To identify factors associated with Routine Reviewer
status while controlling for possible confounders, multivari-
ate logistic regression was used with age and T1D duration in
separate models because of the possibility of collinearity.
Among adults, both older age (odds ratio = 1.04; 95% con-
fidence interval, 1.01, 1.08; P = 0.02) and longer T1D du-
ration (odds ratio = 1.05; 95% confidence interval, 1.01,
1.09; P = 0.01) remained associated with Routine Reviewer
status, after controlling for sex, minority status, education,
and insurance status. For every 10-year increase in age,
there was 1.5 (95% confidence interval, 1.1, 2.1) times in-
creased odds of being a Routine Reviewer, and for every 10
years since diagnosis, there was 1.7 (95% confidence in-
terval, 1.2, 2.4) times increased odds of being a Routine
Reviewer. For caregivers, age of the child and T1D duration
were not significantly associated with the caregiver being a
Routine Reviewer in adjusted analysis. However, there were
trends toward caregivers of younger children (odds ratio= 0.93;
95% confidence interval, 0.85, 1.0; P= 0.13) and of children
with shorter T1D diagnosis (odds ratio= 0.89; 95% confidence
interval, 0.79, 1.0; P= 0.05) being associated with Routine
Reviewer status. Separate multivariate models showed no as-
sociations of being a Routine Reviewer with A1c in either
group (data not shown).
Preliminary assessment of obstacles to downloading
and reviewing device data
Participants were asked to choose from a list of reasons or
provide other explanations why they did not regularly down-
load data from their devices. Responses were not mutually
exclusive. The responses were grouped into eight categories,
in addition to reasons specific to BGM or CGM data (Table 3).
Major reasons included the following: lack of proper equip-
ment; lack of awareness that downloading data was possible or
recommended; lack of knowledge of how to download the
data; lack of time, motivation, or interest; technical reasons;
lack of understanding or dislike of the software; use of alter-
native methods to view data; and being a new user. Common
reasons for not downloading data from BGMs included pref-
erence for using pump and CGM data and the fact that the
BGM data are often transferred to the pump manually or au-
tomatically. A few CGM users commented that they did not
download CGM data because they downloaded data from their
pumps, even though CGM and pump downloads show dif-
ferent, but complementary, information.
Discussion
Although using retrospective data from diabetes devices is
important for insulin adjustment in T1D, which is rec-
ommended between clinic visits, few data exist describing
how often patients acquire and review this information. In
this study, we show that fewer than one-third of adults and
about half of caregivers of children with T1D reported ever
downloading data from at least one of their diabetes devices
in the past year; the number of those who did this routinely
was even less. This was at a diabetes center where use of devices
is higher than other reports, suggesting that in a population with
a relatively high rate of technology use, downloading data is not
a priority. Even fewer still were the numbers of users who
reviewed downloaded information, with only 12% of adults
and 27% of caregivers of children doing this routinely. The
finding that a minority of patients download data from their
devices is in agreement with prior studies.12,23,24 To our
knowledge, this is the first study to report the frequency at
which patients retrospectively review their downloaded
Table 2. Comparisons Between Routine Reviewers and Non-Routine Reviewers of at Least One Device
Participants, characteristic Routine Reviewers Non-Reviewers P
Adults
Number of participants 18 136
Mean age (years) 44.9 – 13.1 32.9 – 16.2 0.003
Sex (% male) 61% 48% 0.29
Ethnicity (% minority status) 11% 27% 0.15
Education level (% with at least college degree)a 83% 66% 0.13
Insurance status (% with non-private insurance) 11% 25% 0.18
Mean duration of type 1 diabetes (years) 28.7 – 15.5 17.2 – 12.7 0.0006
Mean A1c (%) 7.2 – 1.0 8.1 – 1.6 0.03
Children
Number of participants 50 132
Mean age of child (years) 10.8 – 4.0 12.3 – 3.9 0.02
Sex of child (% male) 58% 53% 0.55
Ethnicity (% minority status) 14% 21% 0.33
Caregiver education (% with at least college degree) 75% 64% 0.17
Insurance status (% with non-private insurance) 11% 22% 0.10
Mean duration of type 1 diabetes (years) 3.7 – 3.1 5.5 – 3.8 0.005
Mean A1c (%) 7.8 – 1.4 8.6 – 1.7 0.001
Unadjusted mean– SD values or frequencies are shown, as indicated. P values were obtained from t tests for continuous variables and
v2 tests for dichotomous variables.
aParticipants 18 to < 26 years of age were categorized as having a college degree if they had completed at least some college.
A1c, hemoglobin A1c.
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data. The results suggest that the majority of patients are not
actively using these retrospective features of their devices.
It is of interest that adult users of CGM and caregivers of
children using pumps downloaded and reviewed information
from these devices more regularly than did users of other
devices. This suggests that adult patients find data from CGM
more useful than that collected from other devices, or that
CGM software may be easier to use. We acknowledge that
increased frequency of CGM download and review may rep-
resent a selection bias that cannot be addressed by this cross-
sectional study; adults who choose to use CGM may be more
likely than the general T1D population to review their data. For
caregivers, users of pumps more routinely downloaded and
reviewed pump data, suggesting that pump downloads are more
useful for those managing diabetes in their children. One factor
that might influence this difference between adult patients and
caregivers is that our pediatric providers routinely download
and review device data with families at each clinic visit, and the
pediatric practice encourages caregivers to download device
data at home and send them to providers to review between
visits. In contrast, the adult practice does not routinely down-
load device data in the clinic, but instead asks patients to keep
paper logs or bring hardcopies of the downloads to visits.
Providers in the adult practice also do not regularly review
patient-generated downloads between visits, and patients are
expected to review data on their own. This difference in clinical
Table 3. Reasons for Not Downloading Data from Devices
Major categories
Multiple choice
options given Other participant responses
Lack of proper
equipment
 I don’t have
a computer.
 ‘‘I don’t have the software or the cord
to connect the meter.’’
 ‘‘I wasn’t given the cord.’’
 ‘‘Lost the connector.’’
 ‘‘No software available.’’
Unaware that downloading
data was possible
or recommended
 ‘‘Not requested.’’
 ‘‘I didn’t know I could.’’
 ‘‘Doctor didn’t ask.’’
 ‘‘Didn’t know that I could do that.’’
Don’t know how
to download data
 I don’t know how
to download the device.
 ‘‘Misplaced information.’’
 ‘‘Not comfortable downloading.’’
Lack of time, motivation,
or interest
 I didn’t have time.
 I forgot.
 I don’t need the
information from
the download.
 ‘‘Lots of time.’’
 ‘‘Not interested in using the software.’’
 ‘‘Lazy.’’
 ‘‘I didn’t have the focus.’’
 ‘‘Forgot to even load the software.’’
Technical reasons  The software program
did not work.
 The software is not
compatible with
my computer.
 ‘‘Does not support Windows 8.’’
 ‘‘Incompatible with Mac.’’
 ‘‘Need to set up a new password.’’
 ‘‘Technology is incomplete.’’
Don’t understand
or like the software
 I don’t know what
to do with the
information.
 ‘‘Awkward/slow interface.’’
 ‘‘Device readings cannot be trusted’’
 ‘‘Graphs are too complicated and hard
to make sense of.’’
 ‘‘Software is clumsy.’’
 ‘‘The graphs are hard to read, overwhelming.’’
Alternative methods  ‘‘I can write it down.’’
 ‘‘I write everything down and look at it constantly.’’
 ‘‘Use a paper log.’’
New user  ‘‘6 months into diagnosis, but ideally see the benefit.’’
 ‘‘Brand new to CGM’’
 ‘‘Just did a trial week’’
 ‘‘Just got new meter last week’’
 ‘‘Just started using it’’
BGM-specific reasons  ‘‘CGM gives better data.’’
 ‘‘Download pump if need info.’’
 ‘‘Have a CGM.’’
 ‘‘The numbers connect to my pump.’’
 ‘‘We enter blood glucose info into pump.’’
 ‘‘We use the pump upload instead.’’
CGM-specific reasons  ‘‘I only download from pump.’’
 ‘‘We upload [the pump] instead.’’
BGM, blood glucose meter; CGM, continuous glucose monitoring.
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practice is not atypical of pediatric compared with adult clin-
ics27 and may explain why frequency of downloading and re-
viewing data was higher overall among caregivers in the
pediatric practice. It also suggests that if providers actively
download and use the data in the clinic, this may influence
patients to independently adopt these practices. Further studies
are required to test this hypothesis.
In adjusted analysis, the relationship between age and T1D
duration and the likelihood of routine data review differed be-
tween adults and caregivers of children. Older adults, and those
adults who had diabetes longer, were more likely to be Routine
Reviewers of device data. Data review can be considered a
marker of engagement in self-care. Our finding that this behavior
increases with age is consistent with the fact that self-care im-
proves as emerging adults reach later stages of adulthood.27 It
also parallels the improvement in A1c that occurs with age after
adolescence,26 suggesting that review of data, increased self-
care, and more optimal A1c may be related. In contrast, there
was a trend that caregivers of younger children and of those with
a newer diagnosis were more likely to review device data,
suggesting that caregivers of younger children, or of those with a
more recent diagnosis, interact with data more often. This agrees
with other findings that parental involvement in diabetes man-
agement declines as a child progresses through adolescence.28,29
These findings in both groups indicate that data download and
review are most often neglected in adolescents and young adults.
Although unadjusted analysis showed that those who more
frequently reviewed device data had lower mean A1c, we did
not detect a significant association between those who were
Routine Reviewers of their data and A1c after adjustment. This
may be because our study was not powered to detect these
differences, and a larger sample size and/or prospective study
may be necessary to evaluate an association between patient
self-review of data and glycemic control. In addition, this study
did not explore how patients used device data after they re-
viewed them; it is not known if they sent the data to a provider,
made changes to their insulin plans on their own, or understood
or did anything with the information from their devices. It is
possible that simply asking patients to download and review
their data, without knowing how they are interpreting and
using it, does not have an impact on A1c. Further qualitative
studies are necessary to determine what patients understand
about their data downloads, given the current tools available,
and what they do with the information. Others have enforced
the need for continuing education and training in interpreting
and applying device data.10,30 Better tools, resources, and ed-
ucation regarding use of diabetes data may be necessary in
order for self-review to influence glycemic control.
The need for better tools to obtain diabetes data was sug-
gested by our preliminary look at obstacles to downloading
and reviewing data. Although some participants felt that there
was no need to review the data, many reasons reflected a lack
of knowledge or proper equipment, technical difficulties, or
frustration with the available hardware and software appli-
cations. Looking forward, providers should educate patients
on the process of data download, when and how it should be
done, and how to interpret and use the information. These
results also suggest the need for more seamless, less time-
intensive methods of data acquisition from devices and for
easily understandable forms of data visualization.
We recognize the limitations of our study. These include
its cross-sectional nature and the use of self-reported data.
However, in cases of self-reported ‘‘favorable’’ behavior,
there is a tendency to overreport.31,32 Also, patients may have
considered any downloading events immediately prior to
their clinic visit (for use by the diabetes provider) in their
frequency of downloading data at home. If this is true, the
actual frequency of independent download and review of data
between clinic visits may be even lower than reported. We
acknowledge that our definition of ‘‘routine’’ download and
review was conservative, knowing that other studies asked
patients to download data weekly or monthly12,24 or con-
sidered weekly download to be a target.23,26 The number of
participants who downloaded or reviewed data weekly would
be smaller by these more stringent definitions. As mentioned,
we had a high percentage of device users, suggesting an af-
finity or comfort with technology in our population that might
not be present in all general T1D populations. This might
suggest that the frequency of downloading and reviewing
data in a population that is more technology-averse could be
even lower. Finally, although our survey inquired about data
review, we do not specifically know the actions that patients
took after downloading and reviewing their data. Further
studies will enable us to gain a better understanding of how
patients review data on their own and if any of these actions is
associated with improved glycemic control.
In summary, a minority of patients with T1D and care-
givers of children with T1D routinely retrospectively reviews
past data from diabetes devices. Future research will deter-
mine if patient self-review influences glycemic control, and
effort should be made to help patients better understand and
use their data. Regardless of how patients use data on their
own, because providers can use device data to adjust insulin
regimens, patients should be educated on how to acquire and
communicate their data to their providers for review between
visits. In particular, young adults and caregivers of adoles-
cents review data less routinely and should be specifically
targeted for educational efforts. Improvements in device
hardware and software could facilitate the data review pro-
cess, making data collection, visualization, and interpretation
easier in the future.
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